+1 (704) 266-3234

Global Neuromodulation Devices And Implantable Infusion Pumps Market Insights, Forecast To 2025

Published on: Oct 2018 | From USD $4900 | Published By: QY RESEARCH | Number Of Pages: 114

This report studies the global market size of Neuromodulation Devices and Implantable Infusion Pumps in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neuromodulation Devices and Implantable Infusion Pumps in these regions.
This research report categorizes the global Neuromodulation Devices and Implantable Infusion Pumps market by top players/brands, region, type and end user. This report also studies the global Neuromodulation Devices and Implantable Infusion Pumps market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.

USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units’ implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.

With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.

It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.

The global Neuromodulation Devices and Implantable Infusion Pumps market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Neuromodulation Devices and Implantable Infusion Pumps market based on company, product type, end user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical

Market size by Product
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Market size by End User
Parkinson's disease
Epilepsy
Pain
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Neuromodulation Devices and Implantable Infusion Pumps market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Neuromodulation Devices and Implantable Infusion Pumps market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neuromodulation Devices and Implantable Infusion Pumps companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neuromodulation Devices and Implantable Infusion Pumps submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Neuromodulation Devices and Implantable Infusion Pumps are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neuromodulation Devices and Implantable Infusion Pumps market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Neuromodulation Devices and Implantable Infusion Pumps Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Product
1.4.2 Spinal Cord Stimulation
1.4.3 Deep Brain Stimulation
1.4.4 Sacral Nerve Stimulation
1.4.5 Vagal Nerve Stimulation
1.4.6 Gastric Stimulation
1.4.7 Transcranial magnetic Stimulation
1.4.8 Transcutaneous Electrical Stimulation
1.4.9 Other
1.5 Market by End User
1.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by End User
1.5.2 Parkinson's disease
1.5.3 Epilepsy
1.5.4 Pain
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue 2013-2025
2.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2013-2025
2.2 Neuromodulation Devices and Implantable Infusion Pumps Growth Rate by Regions
2.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Regions
2.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers
3.1.1 Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers
3.1.2 Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers
3.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Ratio (CR5 and HHI)
3.2 Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers
3.2.1 Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers (2013-2018)
3.2.2 Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2013-2018)
3.3 Neuromodulation Devices and Implantable Infusion Pumps Price by Manufacturers
3.4 Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution, Product Types
3.4.1 Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
3.4.3 Date of International Manufacturers Enter into Neuromodulation Devices and Implantable Infusion Pumps Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Product
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.3 Neuromodulation Devices and Implantable Infusion Pumps Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by End User

6 North America
6.1 North America Neuromodulation Devices and Implantable Infusion Pumps by Countries
6.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries
6.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Neuromodulation Devices and Implantable Infusion Pumps by Product
6.3 North America Neuromodulation Devices and Implantable Infusion Pumps by End User

7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Countries
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps by Product
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps by End User

8 Asia Pacific
8.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps by Countries
8.1.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries
8.1.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps by Product
8.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps by End User

9 Central & South America
9.1 Central & South America Neuromodulation Devices and Implantable Infusion Pumps by Countries
9.1.1 Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries
9.1.2 Central & South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Neuromodulation Devices and Implantable Infusion Pumps by Product
9.3 Central & South America Neuromodulation Devices and Implantable Infusion Pumps by End User

10 Middle East and Africa
10.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps by Countries
10.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries
10.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps by Product
10.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps by End User

11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Company Business Overview
11.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.1.5 Medtronic Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.2.5 Boston Scientific Corporation Recent Development
11.3 St. Jude Medical
11.3.1 St. Jude Medical Company Details
11.3.2 Company Business Overview
11.3.St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.3.5 St. Jude Medical Recent Development
11.4 Synapse Biomedical
11.4.1 Synapse Biomedical Company Details
11.4.2 Company Business Overview
11.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.4.5 Synapse Biomedical Recent Development
11.5 Nevro Corporation
11.5.1 Nevro Corporation Company Details
11.5.2 Company Business Overview
11.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.5.5 Nevro Corporation Recent Development
11.6 Neuropace
11.6.1 Neuropace Company Details
11.6.2 Company Business Overview
11.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.6.5 Neuropace Recent Development
11.7 Cyberonics
11.7.1 Cyberonics Company Details
11.7.2 Company Business Overview
11.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.7.5 Cyberonics Recent Development
11.8 Autonomic Technologies
11.8.1 Autonomic Technologies Company Details
11.8.2 Company Business Overview
11.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.8.5 Autonomic Technologies Recent Development
11.9 Avery Biomedical
11.9.1 Avery Biomedical Company Details
11.9.2 Company Business Overview
11.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.9.5 Avery Biomedical Recent Development
11.10 Greatbatch Medical
11.10.1 Greatbatch Medical Company Details
11.10.2 Company Business Overview
11.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2013-2018)
11.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
11.10.5 Greatbatch Medical Recent Development

12 Future Forecast
12.1 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Regions
12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Regions 2018-2025
12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Regions 2018-2025
12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Product
12.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Product 2018-2025
12.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Product 2018-2025
12.3 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by End User
12.4 North America Neuromodulation Devices and Implantable Infusion Pumps Forecast
12.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Forecast
12.6 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Forecast
12.7 Central & South America Neuromodulation Devices and Implantable Infusion Pumps Forecast
12.8 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neuromodulation Devices and Implantable Infusion Pumps Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Neuromodulation Devices and Implantable Infusion Pumps Product Picture
Table Neuromodulation Devices and Implantable Infusion Pumps Market Segments
Table Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Covered
Table Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product 2013-2025
Figure Spinal Cord Stimulation Product Picture
Table Major Manufacturers of Spinal Cord Stimulation
Figure Deep Brain Stimulation Product Picture
Table Major Manufacturers of Deep Brain Stimulation
Figure Sacral Nerve Stimulation Product Picture
Table Major Manufacturers of Sacral Nerve Stimulation
Figure Vagal Nerve Stimulation Product Picture
Table Major Manufacturers of Vagal Nerve Stimulation
Figure Gastric Stimulation Product Picture
Table Major Manufacturers of Gastric Stimulation
Figure Transcranial magnetic Stimulation Product Picture
Table Major Manufacturers of Transcranial magnetic Stimulation
Figure Transcutaneous Electrical Stimulation Product Picture
Table Major Manufacturers of Transcutaneous Electrical Stimulation
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Parkinson's disease
Figure Epilepsy
Figure Pain
Figure Other
Figure Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Market Size 2013-2025 (Million US$)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2013-2025 (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Regions 2013-2018 (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Regions 2013-2018
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Regions 2013-2018
Figure 2017 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Regions
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Regions 2013-2018 (Million US$)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions 2013-2018
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions 2013-2018
Figure 2017 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (2013-2018) (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers (2013-2018) (Million USD)
Table Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2013-2018)
Figure Neuromodulation Devices and Implantable Infusion Pumps Value Share by Manufacturers in 2017
Table Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Price (2013-2018) (USD/Unit)
Table Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table Date of International Manufacturers Enter into Neuromodulation Devices and Implantable Infusion Pumps Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Product (2013-2018) (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Product (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product in 2017
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product (2013-2018) (Million US$)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Product (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Product (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Product in 2017
Table Neuromodulation Devices and Implantable Infusion Pumps Price by Product 2013-2018 (USD/Unit)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by End User (2013-2018) (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by End User (2013-2018)
Figure Global Sales Neuromodulation Devices and Implantable Infusion Pumps Market Share by End User (2013-2018)
Figure Global Sales Neuromodulation Devices and Implantable Infusion Pumps Market Share by End User in 2017
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2013-2018 (K Units)
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2013-2018 (Million US$)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018) (K Units)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure 2017 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries
Table North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018) (Million US$)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries
Figure United States Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure United States Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Product (2013-2018) (K Units)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product (2013-2018)
Figure 2017 North America Neuromodulation Devices and Implantable Infusion Pumps Market Share by Product
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales by End User (2013-2018) (K Units)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by End User (2013-2018)
Figure 2017 North America Neuromodulation Devices and Implantable Infusion Pumps Market Share by End User
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2013-2018 (K Units)
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018) (K Units)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018) (Million US$)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries
Figure Germany Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure France Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure UK Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Product (2013-2018) (K Units)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product (2013-2018)
Figure 2017 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Share by Product
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by End User (2013-2018) (K Units)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by End User (2013-2018)
Figure 2017 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Share by End User
Figure Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries
Figure China Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure India Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Product (2013-2018) (K Units)
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Share by Product
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by End User (2013-2018) (K Units)
Table Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Share by End User
Figure Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018) (K Units)
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries
Figure Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Product (2013-2018) (K Units)
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Neuromodulation Devices and Implantable Infusion Pumps Market Share by Product
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales by End User (2013-2018) (K Units)
Table Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Neuromodulation Devices and Implantable Infusion Pumps Market Share by End User
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries
Figure GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Share by Product
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Share by End User
Table Medtronic Company Details
Table Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Medtronic Recent Development

Table Boston Scientific Corporation Company Details
Table Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Boston Scientific Corporation Recent Development

Table St. Jude Medical Company Details
Table St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table St. Jude Medical Recent Development

Table Synapse Biomedical Company Details
Table Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Synapse Biomedical Recent Development

Table Nevro Corporation Company Details
Table Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Nevro Corporation Recent Development

Table Neuropace Company Details
Table Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Neuropace Recent Development

Table Cyberonics Company Details
Table Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Cyberonics Recent Development

Table Autonomic Technologies Company Details
Table Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Autonomic Technologies Recent Development

Table Avery Biomedical Company Details
Table Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Avery Biomedical Recent Development

Table Greatbatch Medical Company Details
Table Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Greatbatch Medical Recent Development

Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Regions 2018-2025 (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Regions 2018-2025
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Regions 2018-2025
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Product 2018-2025 (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Product 2018-2025
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Product 2018-2025
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by End User 2018-2025 (K Units)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by End User 2018-2025
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Neuromodulation Devices and Implantable Infusion Pumps Value Chain
Table Neuromodulation Devices and Implantable Infusion Pumps Customers List
Table Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4900
USD $5900
USD $9800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.